课题基金 / 基金详情

DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT)

DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT)
透析症状控制-瘙痒结果试验 (DISCO-POT)
批准号:
438067
负责人:
Collister David
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2021-10-01

项目摘要

项目成果

Collister David的其他基金

相似基金

相关文献

中文摘要
翻译
与肾脏疾病相关的瘙痒影响了一半以上的透析患者。它是研究的重中之重,因为它对生活质量有负面影响。为什么瘙痒在透析患者中如此普遍尚不完全清楚,但很有可能
英文摘要
Itching associated with kidney disease affects more than half of patients on dialysis. It is a top research priority because of its negative impact on quality of life. Why itching is so common in dialysis patients is not fully understood but it is likely
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of gender affirming hormone therapy on biomarkers of kidney function and glomerular filtration rate in transgender adults
  • 批准号:
    469625
  • 项目类别:
    Operating Grants
  • 资助金额:
    $35.67万
  • 财政年份:
    2022
  • 负责人:
    Collister David
  • 依托单位:
REsponSiveness of urEmic sympToms to DIALYSIS (RESET-DIALYSIS)
  • 批准号:
    444140
  • 项目类别:
    Operating Grants
  • 资助金额:
    $23.41万
  • 财政年份:
    2021
  • 负责人:
    Collister David
  • 依托单位:
Dialysis Symptom Control-Restless Legs Syndrome (DISCO-RLS) trial
  • 批准号:
    387082
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Collister David
  • 依托单位:
The DIalysis Symptom Control (DISCO) Trial: a 2x2 factorial pilot randomized placebo controlled trial of pramipexole and gabapentin for restless legs syndrome in hemodialysis
  • 批准号:
    383297
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $7.65万
  • 财政年份:
    2017
  • 负责人:
    Collister David
  • 依托单位:
海外基金